Classical and novel pharmacological insights offered by the simple chick cardiomyocyte cell culture model: a valuable teaching aid and a primer for “real” research

2017 ◽  
Vol 41 (1) ◽  
pp. 163-169 ◽  
Author(s):  
N. S. Freestone ◽  
C. L. S. Sam

The chick embryo cardiomyocyte model of cell culture is a staple technique in many physiology and pharmacology laboratories. Despite the relative simplicity, robustness, and reproducibility inherent in this model, it can be used in a variety of ways to yield important new insights that help facilitate student understanding of underlying physiological and pharmacological concepts as well as, more generally, the scientific method. Using this model, this paper will show real data obtained by undergraduate students in the authors’ laboratories. It will first demonstrate classical pharmacological concepts such as full and partial agonism, inverse agonism, and competitive reversible antagonism and then move on to more complex pharmacology involving the characterization of novel receptors in these cells.

Il Farmaco ◽  
1999 ◽  
Vol 54 (9) ◽  
pp. 594-599 ◽  
Author(s):  
Elia Biganzoli ◽  
Luigi A Cavenaghi ◽  
Roberta Rossi ◽  
Maria C Brunati ◽  
Maria L Nolli

2012 ◽  
Vol 315 (2) ◽  
pp. 178-188 ◽  
Author(s):  
Hannah van Malenstein ◽  
Chris Verslype ◽  
Petra Windmolders ◽  
Rudy van Eijsden ◽  
Frederik Nevens ◽  
...  

1977 ◽  
Vol 59 (2) ◽  
pp. 206-227 ◽  
Author(s):  
Leslie P. Kozak ◽  
John J. Eppig ◽  
Doris Dahl ◽  
Amico Bignami

2020 ◽  
Vol 92 (18) ◽  
pp. 12538-12547 ◽  
Author(s):  
Lucy E. Flint ◽  
Gregory Hamm ◽  
Joseph D. Ready ◽  
Stephanie Ling ◽  
Catherine J. Duckett ◽  
...  

2021 ◽  
Vol 69 (9) ◽  
pp. 2711-2718
Author(s):  
Ritian Jin ◽  
Jiaqi Shang ◽  
Xiangyu Teng ◽  
Ligang Zhang ◽  
Minhe Liao ◽  
...  

Genes ◽  
2010 ◽  
Vol 1 (3) ◽  
pp. 388-412 ◽  
Author(s):  
Verena L. Bauer ◽  
Ludwig Hieber ◽  
Quirin Schaeffner ◽  
Johannes Weber ◽  
Herbert Braselmann ◽  
...  

2019 ◽  
Vol 116 (48) ◽  
pp. 24310-24316 ◽  
Author(s):  
Yumiko V. Taguchi ◽  
Erica L. Gorenberg ◽  
Maria Nagy ◽  
Drake Thrasher ◽  
Wayne A. Fenton ◽  
...  

Parkinson’s disease is characterized by the aggregation of the presynaptic protein α-synuclein and its deposition into pathologic Lewy bodies. While extensive research has been carried out on mediators of α-synuclein aggregation, molecular facilitators of α-synuclein disaggregation are still generally unknown. We investigated the role of molecular chaperones in both preventing and disaggregating α-synuclein oligomers and fibrils, with a focus on the mammalian disaggregase complex. Here, we show that overexpression of the chaperone Hsp110 is sufficient to reduce α-synuclein aggregation in a mammalian cell culture model. Additionally, we demonstrate that Hsp110 effectively mitigates α-synuclein pathology in vivo through the characterization of transgenic Hsp110 and double-transgenic α-synuclein/Hsp110 mouse models. Unbiased analysis of the synaptic proteome of these mice revealed that overexpression of Hsp110 can override the protein changes driven by the α-synuclein transgene. Furthermore, overexpression of Hsp110 is sufficient to prevent endogenous α-synuclein templating and spread following injection of aggregated α-synuclein seeds into brain, supporting a role for Hsp110 in the prevention and/or disaggregation of α-synuclein pathology.


Sign in / Sign up

Export Citation Format

Share Document